Astrana Health, Inc.(ASTH)— Stock Profile, AI Score & Financials

Technology · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Astrana Health, Inc. (ASTH) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores ASTH at 60.7/100 on a 32-signal composite quality model, placing it at rank #840 of 2,961 stocks — the top half of the AI-ranked universe. ASTH scores in the top quartile across revenue growth (94.5), earnings quality (80.1). Areas of concern include free cash flow (34.0) and profitability (36.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Astrana Health, Inc. reports quarterly revenue of $972.5M, net income of $19.7M, an operating margin of 3.5%. Top institutional holders of ASTH by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ASTH trades on the Nasdaq exchange and files with the SEC under CIK 1083446. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ASTH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Astrana Health, Inc. directly from SEC EDGAR.